3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
124
Precursor Cell Lymphoblastic Leukemia-Lymphoma
76
Leukemia
66
Myelodysplastic Syndromes
56
Lymphoma
34
Lymphoma, Non-Hodgkin
33
Leukemia, Lymphocytic, Chronic, B-Cell
30
Hodgkin Disease
27
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
26
Burkitt Lymphoma
25
Multiple Myeloma
24
Lymphoma, Mantle-Cell
19
Lymphoma, Follicular
18
Hematologic Neoplasms
18
Lymphoma, B-Cell, Marginal Zone
17
Lymphoma, Large B-Cell, Diffuse
16
Leukemia, Biphenotypic, Acute
16
Recurrence
15
Myeloproliferative Disorders
15
Congenital Abnormalities
15
Leukemia, Myelomonocytic, Chronic
13
Anemia, Refractory, with Excess of Blasts
13
Lymphoma, Large-Cell, Immunoblastic
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Blast Crisis
10
Graft vs Host Disease
9
Neoplasms, Plasma Cell
8
Leukemia, Myelomonocytic, Juvenile
8
Primary Myelofibrosis
7
Leukemia, Myelomonocytic, Acute
7
Interventions
Specimen Handling
1
Granulocyte Colony-Stimulating Factor
1
Genetic Counseling
1
Filgrastim
1
Decitabine
1
Clinical Trials, Phase I as Topic
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Congenital Bone Marrow Failure Syndromes
×
Granulocyte Colony-Stimulating Factor
×
Other hematologic neoplasm
×
Clear all
NCT05796570
2026-03-19
MORE
Dana-Farber Cancer Institute
Phase 2
Recruiting
37 enrolled